l.wikstrom

TL2 · Osijek

Contributes reviews on supplier material. Based in Osijek.

Joined 20 February 2025 · last posted 17h

83 posts, newest first. Showing up to 150.

How shortages have affected compounding permissions — does this still hold? Replied, post #32 · Access › Shortages · 27 Jul 2026 · 18 likes Trying to state the shortages position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Insomnia at a dose step: reported experiences — the long version Replied, post #52 · Wellbeing › Sleep · 27 Jul 2026 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. Sleep quality changes reported here have several plausible contributors, and…
What a good consultation looks like from the other side Replied, post #61 · Clinical › Prescriber conversations · 21 Jul 2026 · 3 likes Post #59 is right about the mechanism and I think understates the practical bit. One more thing on good consultation that took me far too long to see: the two figures…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #50 · Start Here › Welcome · 16 Jul 2026 · 18 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #43 · Compounds › Retatrutide · 14 Jul 2026 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
How much context is too much context in a first post? Replied, post #72 · Start Here › How to Ask · 10 Jul 2026 · 15 likes I read post #70 twice before replying, because I had assumed the opposite. Disagreement-style questions: "I read this and it contradicts what I heard here, which is…
Insurance and replacement policies, compared Replied, post #71 · Sourcing › Logistics · 7 Jul 2026 · 10 likes Worth separating two things that post #69 runs together. Worth stating the null on insurance and replacement policies before we explain it: the observation may be…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #40 · Compounds › Retatrutide · 5 Jul 2026 · 7 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #2 · Analytics › COA interpretation · 2 Jul 2026 · 9 likes Nobody has said the unglamorous part of Batch date yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Second pass at: When your prescriber and the evidence disagree Replied, post #42 · Clinical › Prescriber conversations · 28 Jun 2026 · 4 likes Agreed on all of that, and I have nothing to add to it.
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #35 · Pharmacology › Pharmacokinetics · 27 Jun 2026 · 6 likes Post #33 is right about the mechanism and I think understates the practical bit. Area under the curve is the exposure measure that matters for most effects in this…
Osteoarthritis and mechanical versus metabolic improvement Replied, post #4 · Clinical › Comorbidities · 26 Jun 2026 · 9 likes My experience of osteoarthritis and mechanical versus metabolic contradicts the reply above. I am posting it as a data point rather than as a refutation, because one…
Angle of injection and whether 90 degrees is always right — the long version Replied, post #30 · Practice › Administration · 23 Jun 2026 · 4 likes Thank you for taking the time. That was more work than a reply usually is.
When a dose reduction is the correct response to a side effect Replied, post #29 · Practice › Dosing & titration · 13 Jun 2026 · 29 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
Reading a trial's population section before its results Replied, post #106 · Evidence › Trials · 9 Jun 2026 · 2 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
Racemisation and why it is invisible to a mass measurement Replied, post #8 · Analytics › Impurities & related substances · 8 Jun 2026 · 0 likes Storage-related degradation and synthesis-related impurity look different on a chromatogram. A growing oxidation peak over time is not a manufacturing finding. Worth…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #81 · Practice › Storage & stability · 7 Jun 2026 · 2 likes Confirming post #80 from a second method, which matters more than confirming it from a second person. A beyond-use date on a home preparation is an inference rather…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #79 · Sourcing › Red flags · 6 Jun 2026 · 10 likes Confirming post #76 from a second method, which matters more than confirming it from a second person. Adding a null result on certificate whose chromatogram axes. I…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #26 · Analytics › Method validation · 5 Jun 2026 · 10 likes Adding the measurement that post #25 says would settle it. Range and working range are different things and a certificate rarely distinguishes them. The relevant one is…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #72 · Evidence › Journal club · 31 May 2026 · 0 likes An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second. For what it is worth, the same held on the…
Reading a trial's population section before its results Replied, post #50 · Evidence › Trials · 24 May 2026 · 0 likes That reframing is the whole thing. The facts I already had.
Blind submission and why it changes minds — the long version Replied, post #87 · Sourcing › Independent verification · 20 May 2026 · 13 likes The claim about Blind submission upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Five questions in one post gets you one answer — how to split them Replied, post #74 · Start Here › How to Ask · 7 May 2026 · 4 likes Post #73 is the version of this I will quote in future. One addition. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #131 · Pharmacology › Pharmacokinetics · 6 May 2026 · 0 likes Adding a null result on Washout. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Journal club: is percentage weight change the right endpoint? Replied, post #115 · Evidence › Journal club · 29 Apr 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #39 · Evidence › Journal club · 15 Apr 2026 · 25 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. If that is…
Follow-up: Reconciling a label claim with a content assay Replied, post #10 · Analytics › COA interpretation · 15 Mar 2026 · 8 likes My understanding of Reconciling a label claim is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating…
[2026 update] What a good consultation looks like from the other side Replied, post #19 · Clinical › Prescriber conversations · 4 Mar 2026 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Personal import allowances, compared — a second dataset Replied, post #79 · Access › International · 4 Mar 2026 · 13 likes That is a cleaner way of putting what I was circling around.
Choosing a concentration on purpose rather than by accident Replied, post #2 · marked as the solution · Practice › Reconstitution · 25 Feb 2026 · 8 likes Everything in the opening post holds. The case it does not cover is the one I have. Concentration is total mass divided by total volume, and everything else follows…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #81 · Evidence › Study critique · 24 Feb 2026 · 3 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #16 · Start Here › Welcome · 22 Feb 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Second pass at: Metformin co-administration and additive GI effects Replied, post #42 · Practice › Interactions · 31 Jan 2026 · 5 likes I read post #41 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #59 · Analytics › Method validation · 29 Jan 2026 · 0 likes Post #55 describes the usual case. This is about the unusual one. Specificity is the first question: does the method separate the analyte from everything reasonably…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #85 · Clinical › Special populations · 26 Jan 2026 · 29 likes Second this, and I would have said it less carefully.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #68 · Clinical › Special populations · 24 Jan 2026 · 23 likes Before the thread moves on from Pregnancy and pregnancy planning — what is the sample size behind the claim? I am not being difficult; I have seen the same figure…
A plateau that disappeared when I changed how I measured — the long version Replied, post #3 · Outcomes › Progress reports · 24 Jan 2026 · 5 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #39 · Devices › Pens & autoinjectors · 22 Jan 2026 · 3 likes A pen that has been dropped may not be visibly damaged and may not deliver accurately afterwards. Manufacturers say to replace rather than to test, and there is no test…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #98 · Compounds › Oral incretins · 18 Dec 2025 · 10 likes Helpful, and easy to find again, which is half of what a good reply is.
DXA precision and the least significant change for lean mass Replied, post #55 · Outcomes › Body composition · 9 Dec 2025 · 33 likes Coming back to post #53, because the follow-up matters more than the original answer. DXA on the same machine with the same technician has a least significant change…
Tracking a preprint to publication: a worked example Replied, post #85 · Evidence › Preprints · 8 Dec 2025 · 2 likes Two claims get bundled together under tracking a preprint and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
When to stop reading forums, including this one Replied, post #59 · Wellbeing › Mental health · 8 Dec 2025 · 18 likes Mood changes reported during substantial weight loss have several plausible contributors and the drug is only one of them. Energy restriction alone is a well-documented…
Reading SURMOUNT-1 without the press release Replied, post #90 · Compounds › Tirzepatide · 5 Dec 2025 · 1 like Two sentences on reading SURMOUNT-1 without the press and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
Run-in periods and the population they select Replied, post #31 · Evidence › Trials · 5 Dec 2025 · 4 likes On post #29 — agreed on the reasoning, with one qualification. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
Cross-border purchase rules within the EU Replied, post #45 · Regional › European Union · 27 Nov 2025 · 4 likes The arithmetic in post #42 is right; the assumption feeding it is the part to check. I would put moderate confidence on the mainstream reading of cross-border purchase…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #25 · Practice › Side effects · 25 Nov 2025 · 14 likes Two questions I would want answered before drawing anything from the Injection-site reactions data above: how were the cases selected, and what happened to the ones…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #61 · Compounds › Other compounds · 24 Nov 2025 · 2 likes Post #60 is right about the mechanism and I think understates the practical bit. Solubility varies far more across this subcategory than within the incretins. A…
Lurking for two months before posting: was that the right call? Replied, post #65 · Start Here › Welcome · 20 Nov 2025 · 2 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
Pen dose counters: what a click does and does not guarantee Replied, post #113 · Devices › Pens & autoinjectors · 20 Nov 2025 · 27 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
Long-time reader, first-time poster Replied, post #6 · Lounge › Introductions · 5 Nov 2025 · 0 likes Long-time reader is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
Second pass at: Programming during a large energy deficit Replied, post #57 · Nutrition & Training › Resistance training · 28 Oct 2025 · 31 likes I read post #55 twice before replying, because I had assumed the opposite. Strength and hypertrophy respond to different things, and preserving one during a deficit is…
Waist circumference technique and its repeatability Replied, post #8 · Outcomes › Progress reports · 18 Oct 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Compounds this community declines to help with, and why Replied, post #85 · Compounds › Other compounds · 8 Oct 2025 · 15 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Trust level 3 requirements: a clarification Replied, post #11 · Meta › Announcements · 8 Oct 2025 · 0 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 2 likes Useful. I have added it to my own notes with the date on it.
Pinch or no pinch, and how needle length changes the answer Replied, post #81 · Practice › Administration · 27 Sep 2025 · 16 likes On pinch: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
Substitution between formats during a shortage Replied, post #63 · Access › Shortages · 25 Sep 2025 · 0 likes Taking post #60 at face value and following it one step further. Regional differences during a shortage are large, and a supply position in one country says nothing…
Titles that describe the question, not the situation — what changed since Replied, post #26 · Start Here › How to Ask · 19 Sep 2025 · 5 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. The part…
Research-use-only labelling: what it means and what it does not Replied, post #33 · Sourcing › Regulatory · 13 Sep 2025 · 4 likes Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality.
Pooling trials with different estimands — what changed since Replied, post #12 · Evidence › Meta-analyses · 11 Aug 2025 · 0 likes Where the included trials share a sponsor and a protocol template, their errors correlate and pooling does not average them out. That matches what I was told, which is…
Coming back to: What published stability data actually covers, and what it does not Replied, post #107 · Practice › Storage & stability · 7 Aug 2025 · 0 likes Confirming post #106 from a second method, which matters more than confirming it from a second person. Published stability data applies specifically to the formulation…
How to research a compound with no human data without deceiving yourself Replied, post #50 · Compounds › Other compounds · 1 Aug 2025 · 2 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
Comparing my trajectory with the trial curves, carefully Replied, post #29 · Outcomes › Progress reports · 28 Jul 2025 · 2 likes Taking post #26 at face value and following it one step further. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and…
High-resolution MS on aggregates and what it can see Replied, post #27 · Analytics › Mass spectrometry · 21 Jul 2025 · 0 likes Worth separating high-resolution as a question about the compound from high-resolution as a question about the documentation. They get answered by different people and…
Repeatability versus intermediate precision Replied, post #4 · Analytics › Method validation · 16 Jun 2025 · 26 likes Building on post #3 rather than restating it. The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents…
Pre-registering a personal experiment, seriously Replied, post #69 · Research Methods › N-of-1 designs · 31 May 2025 · 14 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #70 · Practice › Reconstitution · 13 May 2025 · 12 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Follow-up: History of disordered eating and why it changes the conversation Started this topic · Clinical › Special populations · 21 Apr 2025 · 7 likes Posting this under the heading it deserves: History of disordered eating and why it changes the conversation Everything below is what sits behind that. What changes if…
Validating a calculator against hand arithmetic — what changed since Replied, post #20 · Data & Tools › Calculators · 17 Apr 2025 · 4 likes The honest answer on Validating a calculator against hand is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how…
Retatrutide dose escalation in the published trials Replied, post #30 · Compounds › Retatrutide · 20 Mar 2025 · 1 like Worth separating two things that post #28 runs together. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect…
Preservatives: function, testing, and limits Replied, post #18 · Pharmacology › Formulation chemistry · 9 Mar 2025 · 21 likes Aggregation is concentration-dependent, which is why reconstituting to a high concentration is not always the convenient choice it appears to be. Marking that as an…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #61 · Devices › Cold chain · 3 Mar 2025 · 23 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #25 · Compounds › Oral incretins · 25 Jan 2025 · 5 likes That is consistent with mine, for whatever one more account is worth.
Oxidation pathways for methionine and tryptophan Replied, post #55 · Analytics › Impurities & related substances · 30 Dec 2024 · 11 likes On oxidation pathways for methionine: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
[2026 update] How to read a forest plot, properly, from scratch Replied, post #3 · Evidence › Trials · 25 Nov 2024 · 8 likes The opening post is the version of this I will quote in future. One addition. Absolute and relative effects answer different questions. Write down the event rate in…
Turnaround times and what they mean for a decision — one year on Replied, post #13 · Sourcing › Independent verification · 11 Nov 2024 · 0 likes Answering the question post #11 raises rather than the one it answers. Repeat determination on the same product line months apart is the measurement that speaks to…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #91 · Clinical › Prescriber conversations · 2 Nov 2024 · 1 like This is the first time the answer has come with its own limits attached. Appreciated.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #117 · Access › Shortages · 13 Oct 2024 · 0 likes Helpful, and short, which on this subject is harder than long.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #28 · Clinical › Comorbidities · 13 Oct 2024 · 4 likes Answering the question post #25 raises rather than the one it answers. Interactions between comorbidities: diabetes and kidney disease together change the risk…
Circumference measurements as a poor man's composition estimate Replied, post #30 · Outcomes › Body composition · 30 Jul 2024 · 18 likes Post #28 put the caveat in the right place and I want to underline it. Practical experience of circumference measurements, offered as one case with the conditions…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #17 · Compounds › Retatrutide · 16 Jul 2024 · 11 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
How this community labels and discusses unrefereed work Replied, post #42 · Evidence › Preprints · 26 Jun 2024 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
The mass-error checker and its intended scope Replied, post #2 · Data & Tools › Calculators · 18 May 2024 · 7 likes Source for the mass-error checker figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…